Dr. Sagman is cofounder and President of C Sixty Inc.  He is a medical oncologist, a fellow of the Royal College of Physicians and Surgeons of Canada, and a fellowship recipient of the Medical Research Council of Canada.  He is a recognized researcher in the field of clinical oncology and has had numerous publications in the field of tumor biology and immunology.  Dr. Sagman is the founder and Executive Director of the Canadian Nanobusiness Alliance, an association dedicated to the promotion of the nanotechnology sector to the business community. Dr. Sagman is the Chairman of GRN Health International Inc., a globally based academic research organization dedicated to medical research and development.  At C Sixty, Dr. Sagman has recruited some of the world's leading scientists, to advance the development of fullerene-based technology to biomedical applications.  To that end, Dr. Sagman has enlisted a comprehensive R&D network, based at leading academic centers, which include Rice University, UCLA, Columbia University, Dartmouth University, the University of Toronto, Erlangen University in Germany, and the University of Taiwan.